Download English IV medicines application | Download Spanish IV medicines application |
Download English oral medicines application | Download Spanish oral medicines application


Program Overview


Phone: 1-877-744-5675
Monday to Friday
9 am to 8 pm Eastern Time
fax: 1-800-708-3430


Mailing Address:
Pfizer First Resource
PO Box 220582
Charlotte, NC 28222-0582

First Resource offers reimbursement support services and patient assistance to help patients gain access to the following Pfizer medicines:
  • Aromasin® (exemestane tablets)
  • Bosulif® (bosutinib) tablets
  • Camptosar®(irinotecan HCl injection)
  • Ellence® (epirubicin hydrochloride injection)
  • Emcyt® (estramustine phosphate sodium capsules)
  • Idamycin® (idarubicin hydrochloride for injection, USP)
  • Inlyta® (axitinib) tablets
  • Neumega® (oprelvekin)
  • Sutent® (sunitinib malate)
  • Torisel® (temsirolimus) injection
  • Xalkori® (crizotinib) capsules
  • Zinecard® (dexrazoxane for injection)
Services for the insured*
First Resource can provide the following benefits for patients with prescription coverage:
  • Reimbursement support services: A First Resource counselor will research and verify patients’ benefits for the medicine they need, outline coverage options and policies, and explain the prior authorization process

  • Alternate funding assistance: First Resource can help patients find alternate sources of funding, if needed. These may include state pharmaceutical assistance programs (SPAPs), Medicaid, Medicare Part D, low-income subsidies, and charitable foundations

  • Appeals process information: If a claim is underpaid or denied, First Resource will investigate and explain the appeals process

  • Specialty pharmacy referral: For patients who have been prescribed Xalkori® (crizotinib) capsules or Inlyta® (axitinib) tablets, First Resource will refer them to an appropriate specialty pharmacy to fill their prescription
Services for the underinsured*
First Resource can provide the following services to patients who have prescription coverage but are experiencing financial hardship (eg, cannot afford their coinsurance or have been denied coverage):
  • Free medicine† and co-payment assistance‡: Patients with prescription coverage who are having trouble paying for their medicines can apply for assistance through First Resource. If they meet income guidelines, they will be eligible to either receive their Pfizer medicine for free, or in some cases, obtain a Co-Pay Card‡ to cover the full cost of their co-pay
Services for the uninsured*
First Resource may be able to help patients without prescription coverage get their Pfizer medicines for free. To qualify for free medicine, patients must:
  • Have no prescription coverage
  • Meet specific income guidelines, adjusted for family size
  • Live in the United States, the US Virgin Islands, or Puerto Rico
  • Be treated by a licensed doctor in the United States or Puerto Rico
Application process
Applying to receive free medicine or co-pay assistance through First Resource is easy. Just follow these 2 steps:
  1. Download either the First Resource IV application or the First Resource oral application.
  2. Patients and their doctors must fill out and fax or mail a completed application, along with proof of income, to First Resource.

    Note: In some urgent cases, patient eligibility can be determined over the phone. First Resource will then send an initial supply of the necessary medicine to the patient’s home or prescriber’s office, depending on the medicine. However, patients must submit a signed and completed application to First Resource within 30 days to continue receiving assistance.

Proof of income includes a copy of one of the following documents that shows total gross annual household income:

  • Previous year’s federal tax return (form 1040 or 1040EZ)
  • Current paycheck stub
  • Wage and tax statements (W-2 forms)
  • Social security, pension, or railroad retirement statements (SSA-1099 or similar)
  • Statements of interest, dividends, or other income (1099-INT, 1099, 1099-DIV, or similar forms)

Application approval
Patients who submit an application by fax or mail will be notified of their acceptance within 2 weeks of applying to the program. If accepted, they will receive their first shipment of medicine at that time. Prescribers will then be responsible for placing any necessary reorders during their patients’ enrollment, which extends for up to one year.
How patients receive their medicines
First Resource will send medicine to a patient’s home or their prescriber’s office, depending on the medicine.

Download brochure

*Services vary by product and eligibility.
†For some products, patients may be required to apply for alternate funding prior to being eligible for free medicine.
‡Co-payment assistance, in the form of a Co-Pay Card, is available for privately insured patients who have been prescribed SUTENT or INLYTA and meet necessary income guidelines.The SUTENT and INLYTA Co-Pay Cards are not health insurance. For a complete list of participating pharmacies for the SUTENT Co-Pay Card, please call the First Resource Program at 1-877-744-5675, or click here. For a complete list of participating pharmacies for the INLYTA Co-Pay Card, please call the First Resource Program at 1-877-744-5675, or visit www.INLYTA.com. There are no membership fees to participate in either Co-Pay Card program. Estimated savings vary and depend on the amount of SUTENT or INLYTA purchased, and the pharmacy where purchased. Average patient savings for SUTENT is $5000. Projected average patient savings for INLYTA is $5000.

Patients who participate in any federal or state programs, such as Medicaid or Medicare, are not eligible for co-payment assistance. However, these patients may be eligible to receive their medicine for free through First Resource. Terms and conditions apply. Speak to a First Resource counselor to learn more.


Contact Us
For additional support, call 1-866-706-2400.
Pfizer Helpful Answers is a joint program of Pfizer Inc and the Pfizer Patient Assistance Foundation™.
Pfizer Helpful Answers is part of Pfizer’s Global Social Investments portfolio. For more information, please visit www.pfizer.com/responsibility.
Copyright © 2013 Pfizer Inc. All rights reserved. Terms of Use | Privacy Policy | | Site Map |
The information provided in this site is intended only for residents of the United States. The products discussed herein may have different product labeling in different countries.